Acetaldophosphamide
| Code | Size | Price |
|---|
| TAR-T29549-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
Acetaldophosphamide is a novel stable aldophosphamide analog.
CAS:
113341-60-9
Formula:
C11H21Cl2N2O6P
Molecular Weight:
379.17
Purity:
0.98
SMILES:
CC(=O)OC(CCOP(N)(=O)N(CCCl)CCCl)OC(C)=O
References
1. Wang YQ, Farquhar D. Aldophosphamide acetal diacetate and structural analogues: synthesis and cytotoxicity studies. J Med Chem. 1991 Jan;34(1):197-203. PubMed PMID: 1992116.
2. Beran M, Andersson BS, Wang Y, McCredie KB, Farquhar D. The effects of acetaldophosphamide, a novel stable aldophosphamide analogue, on normal human and leukemic progenitor cells in vitro: implications for use in bone marrow purging. Cancer Res. 1988 Jan 15;48(2):339-45. PubMed PMID: 3275495.